Total n (%) | No SPC referral n (%) | SPC referral n (%) | OR (95% CI) | |
---|---|---|---|---|
Total | 323 (100) | 168 (100) | 155 (100) | |
Sex | ||||
Male | 178 (55.1) | 92 (54.8) | 86 (55.5) | 1 |
Female | 145 (44.9) | 76 (45.2) | 69 (44.5) | 0.97 (0.63 to 1.51) |
Age, years | ||||
≤60 | 58 (18.0) | 28 (16.7) | 30 (19.3) | 1 |
61–74 | 122 (37.8) | 61 (36.3) | 61 (39.4) | 0.93 (0.50 to 1.74) |
75+ | 143 (44.2) | 79 (47.0) | 64 (41.3) | 0.76 (0.41 to 1.34) |
Diagnosis | ||||
AML | 107 (33.1) | 61 (36.3) | 46 (29.7) | 1 |
DLBCL | 102 (31.6) | 61 (36.3) | 41 (26.4) | 0.89 (0.51 to 1.55) |
Myeloma | 114 (35.3) | 46 (27.4) | 68 (43.9) | 1.96 (1.15 to 3.35) |
Time from diagnosis to death (months) | ||||
≤1 | 75 (23.2) | 59 (35.1) | 16 (10.3) | 1 |
1–6 | 83 (25.7) | 47 (28.0) | 36 (23.2) | 2.82 (1.40 to 5.70) |
6–12 | 62 (19.2) | 25 (14.9) | 37 (23.9) | 5.46 (2.58 to 11.56) |
12+ | 103 (31.9) | 37 (22.0) | 66 (42.6) | 6.58 (3.32 to 13.03) |
Place of death | ||||
Hospital | 240 (74.3) | 138 (82.1) | 102 (65.8) | 1 |
Home | 49 (15.2) | 15 (8.9) | 34 (21.9) | 3.07 (1.59 to 5.93) |
Hospice | 18 (5.6) | 4 (2.4) | 14 (9.0) | 4.74 (1.51 to 14.81) |
Nursing home | 16 (4.9) | 11 (6.6) | 5 (3.2) | 0.62 (0.21 to 1.83) |
AML, acute myeloid leukaemia; DLBCL, diffuse large B-cell lymphoma; SPC, specialist palliative care.